Literature DB >> 3029204

The injurious effect of eosinophil peroxidase, hydrogen peroxide, and halides on pneumocytes in vitro.

J M Agosti, L C Altman, G H Ayars, D A Loegering, G J Gleich, S J Klebanoff.   

Abstract

Recent data suggest that eosinophils may cause lung injury. To determine if the eosinophil peroxidase (EPO)-hydrogen peroxide (H2O2)-halide system could mediate this injury, we added human EPO, H2O2 (or glucose and glucose oxidase as a continuous source of H2O2), and various halides to monolayers of 51Cr-labeled human A549 and rat type II pneumocytes. Cell lysis was measured as soluble 51Cr release. In initial experiments, EPO in solution did not induce lysis under these conditions. Therefore, in subsequent experiments, pneumocytes were preincubated with EPO for 15 minutes, washed to remove unbound enzyme, and then glucose, glucose oxidase, and the halides were added. EPO alone was not injurious, nor was the addition of glucose and glucose oxidase in the absence of EPO. In contrast, the combined addition of EPO, glucose, glucose oxidase, and chloride produced marked target-cell lysis. This effect was time and EPO dose dependent and was enhanced by the addition of iodide. Catalase and azide substantially inhibited the lysis produced by the EPO-H2O2-halide system, suggesting that EPO-catalyzed products of halide oxidation mediated this form of injury. Finally, the addition of eosinophil major basic protein at 10(-5) mol/L to EPO-coated pneumocytes incubated with glucose, glucose oxidase, and halides failed to enhance or inhibit lysis. We hypothesize that the EPO-H2O2-halide system may injure the lung in asthma and eosinophilic pulmonary syndromes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3029204     DOI: 10.1016/0091-6749(87)90368-x

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  25 in total

1.  Protein Radical Formation Resulting from Eosinophil Peroxidase-catalyzed Oxidation of Sulfite.

Authors:  Kalina Ranguelova; Saurabh Chatterjee; Marilyn Ehrenshaft; Dario C Ramirez; Fiona A Summers; Maria B Kadiiska; Ronald P Mason
Journal:  J Biol Chem       Date:  2010-05-25       Impact factor: 5.157

2.  In vitro modulation of the eosinophil-dependent enhancement of the permeability of the bronchial mucosa.

Authors:  C A Herbert; D Edwards; J R Boot; C Robinson
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

Review 3.  Eosinophils: a review.

Authors:  B J McEwen
Journal:  Vet Res Commun       Date:  1992       Impact factor: 2.459

4.  Eosinophilic alveolitis in immunologic interstitial lung disorders.

Authors:  D Olivieri; A Pesci; G Bertorelli
Journal:  Lung       Date:  1990       Impact factor: 2.584

5.  Stimulated eosinophils and proteinases augment the transepithelial flux of albumin in bovine bronchial mucosa.

Authors:  C A Herbert; D Edwards; J R Boot; C Robinson
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

6.  Alteration in the density, morphology, and biological properties of eosinophils produced by bullous pemphigoid blister fluid.

Authors:  M Miyasato; S Tsuda; M Kasada; K Iryo; Y Sasai
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

Review 7.  Biology of the eosinophil.

Authors:  Carine Blanchard; Marc E Rothenberg
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543

Review 8.  Functional role of eosinophils in gastrointestinal inflammation.

Authors:  Simon P Hogan
Journal:  Immunol Allergy Clin North Am       Date:  2009-02       Impact factor: 3.479

9.  Mutual influence between eosinophil peroxidase (EPO) and neutrophils: neutrophils reversibly inhibit EPO enzymatic activity and EPO increases neutrophil adhesiveness.

Authors:  G Zabucchi; R Menegazzi; R Cramer; E Nardon; P Patriarca
Journal:  Immunology       Date:  1990-04       Impact factor: 7.397

10.  Platelet-activating factor induces eosinophil peroxidase release from purified human eosinophils.

Authors:  C Kroegel; T Yukawa; G Dent; P Chanez; K F Chung; P J Barnes
Journal:  Immunology       Date:  1988-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.